25May 2019

PREPARATION AND IN VITRO EVALUATION OF OPTIMIZED FORMULATION OF BI- LAYERED FLOATING TABLET OF SUCRALFATE AND METOPROLOL SUCCINATE.

  • PG Department of Pharmaceutics, Indira Gandhi Institute of Pharmaceutical Sciences, Bhubaneswar.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Objective: The present study based upon the preparation and in vitro evaluation of optimized Bi layered floating tablet (OSFMS)having tablet weight of 400 mg.(214.88 mgofsucralfate& 186 mg of Metoprol succinate). Method: Selection of the formulation, pre compression study, preparation of tablet and in vitro evaluation of tablet. Result: In presence of Lactose MFL, MCC PH 101, Sodium Bicarbonate, Polysorbate 80, Cross povidone of majore amount in Sucralfate layer and in presence of HPMC K 100 M, Sodium Bicarbonate, Eudragit RSPO, Na CMC ,Sodium alginate, HPC, Ethyl Cellulose of majore amount in Metoprolol Succinate layer it produce (OSFMS)tablet having weight of 400 mg.(214.88 mgofSucralfate& 186 mg of Metoprol succinate) produced average drug release 99.92 % and DT of Sucralfate was 1.04 min at acid medium of stomach and TFT of Metoprol Succinate at upper intesine was > 24hours. Conclusion: The optimized formulation of Sucralfate and Metoprolol Succinate (OSFMS) may be considered as a better formulation as Gastro Retaintive Drug Delivery System..

  1. Biswal B .Design development and evaluation of Trimetazidine Di hydrochloride Floating Bi-Layer M.R Tablet .IRJP 2011 ; 7: 92-97.
  2. Garg R K ,Singhvi I. Bilayer Floating Tablet Technology : An Overview ; IJPPR 2015, 3: 302-22.
  3. Kardumpala S, Chetty M, Gnanaprakash K, Venkatesh B, Sankar P. A review on Bilayer Floating Tablets. IJRPS 2013; 2:354-60.
  4. Stomach.ulcer.duringpregnancy,October,8,2015,Available.at https://www.momjunction.com/articles/peptic-ulcer-during pregnancy.00372291#gerf.
  5. Briggs GG, Freeman RK. Drugs in pregnancy and lactation .10th Philadeiphia.PA: Wolters Kluwer Health ; 2015.
  6. Tripathy KD, Essential of Medical pharmacology. 5th Jaypee Brothers Medical Publication ; 2003 : 596.
  7. Mark AB, Laura AM, Louise CK, Kurumanchi SA, Fergus PM, David RH, et al .The hypertensive disorder in pregnancy 2018 ;19: 291-310.
  8. Stomach ulcer during pregnancy, Oct,8,2015;Available at https://www.momjunction.com/articles/peptic-ulcer-during pregnancy.00372291#gerf.
  9. Kirch W, Schafer-Korting M, AxthelmT,Kohier H, Mutschier E. Interaction of atenolol with furesimide and calcium and aluminium salts. ClinPhamacolTher.1981;(30): 429-35.
  10. Sweden N, Metoprol pregnancy and breastfeeding warning . Nov, 24, 2018 :Avilable in https:// www.ncbi.nlm.nih.gov/pumbed/2940080.
  11. Paul B,Stephen PC, Rex NB. Metoprolol,An Updated Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy, in Hypertension, Ischaemic Heart Disease and Related Cardiovascular Disorders. 1986; 5 :75-88.
  12. Regardh CG, Lundborg P, Persson BA, The effect of antacid , metoclopramide,andpropantheline on the bioavilability of metoprolol and atenolol Biopharm Drug Dispos.1981 ; 2 :79-87.

[Sreedhar Ranjan Das, Bibhuti Bhusan Panigrahi and Manoj Kumar.Pani. (2019); PREPARATION AND IN VITRO EVALUATION OF OPTIMIZED FORMULATION OF BI- LAYERED FLOATING TABLET OF SUCRALFATE AND METOPROLOL SUCCINATE. Int. J. of Adv. Res. 7 (May). 890-896] (ISSN 2320-5407). www.journalijar.com

Mr Sreedhar Ranjan Das
Research scholar

DOI:

Article DOI: 10.21474/IJAR01/9111      
DOI URL: http://dx.doi.org/10.21474/IJAR01/9111

Download Full Paper

Download PDF No. of Downloads: 27 | No. of Views: 93